NCT03594760View on ClinicalTrials.gov

PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

18F-DCFPyL IV injection

Patient will receive one injection of 18F-DCFPyL and undergo PET-CT imaging

Trial Locations (1)

H2X 0C1

RECRUITING

Centre Hospitalier de l'université de Montréal, Montreal

All Listed Sponsors
lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT03594760 - PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer | Biotech Hunter | Biotech Hunter